-
Despite Overly Negative Street Expectations, JPMorgan Stays Positive On Wright Medical
Wednesday, July 13, 2016 - 8:37am | 337Read More...Over the last twelve months, Wright Medical Group Inc (NASDAQ: WMGI) has evolved into the only orthopedics company publicly traded on U.S. markets. JPMorgan's Take JPMorgan's Andrew Hanover upgraded Wright Medical from Neutral to Overweight, increasing the December 2017 price target from $21.00 to...
-
The Biggest Winners And Losers You May Have Missed Wednesday
Thursday, August 8, 2013 - 9:20am | 717Read More...When was the last time you did some research on some of those, “off the beaten path” names? Benzinga ran a screen of stocks with a market cap of at least $300 million that trade at least 200,000 shares on average. The below 10 stocks represent the biggest winners and losers from Wednesday that...
-
JP Morgan Raises PT On Tornier To $30
Friday, May 20, 2011 - 6:27am | 26Read More...JP Morgan has raised the price target on Tornier (NASDAQ: TRNX) from $26 to $30 and maintains its Overweight rating.
-
Merrill Lynch Raises PT on Tornier to $26 (TRNX, VOLC)
Tuesday, May 10, 2011 - 7:28am | 132Read More...Merrill Lynch raised its price target on Tornier (NASDAQ: TRNX) to $26. In a research report published today, Merrill named strong Q1 results as a reason for its decision. In the report, Merrill states, "TRNX is growing faster than we anticipated and that faster growth looks to us as if it will...
-
JP Morgan Raises PT On Tornier To $26
Tuesday, May 10, 2011 - 6:19am | 26Read More...JP Morgan has raised the price target on Tornier (NASDAQ: TRNX) from $24 to $26 and maintains its Overweight rating.
